Mark Cuban Sells $38K in NFTs Amid Market Plungeby John Darbie 26.06.2024Billionaire Mark Cuban sells $38.5K in NFTs, lists $66K more, amidst an evolving market as NFT sales plunge by 50% ...
Bitcoin Dips Below $60K: June 2024 Price Analysisby John Darbie 25.06.2024"Bitcoin drops below $60K amid bearish pressure. Analyze BTC’s future with key support, resistance levels, and market dynamics. Stay informed!"
Bitcoin Prices Tumble Below $60,000 Amid Mt Gox Fearsby John Darbie 25.06.2024Bitcoin dips below $60K due to profit-taking, miner selling, and Mt. Gox repayment fears, with experts debating the long-term impact.
ResMed, Inspire Medical Drop After Lilly’s Zepbound Studyby Mark Eisenberg 24.06.2024"ResMed and Inspire Medical stocks plummet after Eli Lilly's Zepbound trial success; Citi downgrades RMD, sees market shift. Read more ...
Eurofins Scientific Stock Plummets Amid Muddy Waters Reportby Mark Eisenberg 24.06.2024Eurofins Scientific stock plunges by 20% amid Muddy Waters' short-seller allegations of complex corporate structure and questionable practices.
Crypto Market Crash: Bitcoin, Ethereum, SHIB Plungeby John Darbie 24.06.2024"Crypto market crashes as BTC, ETH, XRP, SHIB plunge amid macroeconomic uncertainty and massive liquidations. Key support levels at risk."
Bitcoin Trendline Failure: New Investment Opportunities?by John Darbie 23.06.2024Explore Bitcoin's failing trendlines: discover the current market dip, potential opportunities, future predictions, and expert analysis for investors.
Bitcoin Plunge: Unprecedented Negative Sentiment Drives Declineby John Darbie 23.06.2024Bitcoin battles rare FUD wave despite $64k price. Prolonged negative sentiment grips the market, with key indices showing fear and ...
Ethereum’s Gas Prices Plunge: More Affordable Than Everby John Darbie 23.06.2024"Ethereum's gas prices hit record lows, while Layer 2 solutions surge. Discover how these changes are making the network more ...
Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patientsby Mark Eisenberg 22.06.2024Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...